1
|
Oyinbo CA: Secondary injury mechanisms in
traumatic spinal cord injury: A nugget of this multiply cascade.
Acta Neurobiol Exp (Wars). 71:281–299. 2011.PubMed/NCBI
|
2
|
Gwak YS, Hulsebosch CE and Leem JW:
Neuronal-glial interactions maintain chronic neuropathic pain after
spinal cord injury. Neural Plast. 2017:24806892017. View Article : Google Scholar : PubMed/NCBI
|
3
|
Alizadeh A, Dyck SM and Karimi-Abdolrezaee
S: Traumatic spinal cord injury: An overview of pathophysiology,
models and acute injury mechanisms. Front Neurol. 10:2822019.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Bylicky MA, Mueller GP and Day RM:
Mechanisms of endogenous neuroprotective effects of astrocytes in
brain injury. Oxid Med Cell Longev. 2018:65010312018. View Article : Google Scholar : PubMed/NCBI
|
5
|
Kwon BK, Tetzlaff W, Grauer JN, Beiner J
and Vaccaro AR: Pathophysiology and pharmacologic treatment of
acute spinal cord injury. Spine J. 4:451–464. 2004. View Article : Google Scholar : PubMed/NCBI
|
6
|
Kwon BK, Oxland TR and Tetzlaff W: Animal
models used in spinal cord regeneration research. Spine (Phila Pa
1976). 27:1504–1510. 2002. View Article : Google Scholar : PubMed/NCBI
|
7
|
Lukácová N, Halát G, Chavko M and Marsala
J: Ischemia-reperfusion injury in the spinal cord of rabbits
strongly enhances lipid peroxidation and modifies phospholipid
profiles. Neurochem Res. 21:869–873. 1996. View Article : Google Scholar : PubMed/NCBI
|
8
|
Emery E, Aldana P, Bunge MB, Puckett W,
Srinivasan A, Keane RW, Bethea J and Levi AD: Apoptosis after
traumatic human spinal cord injury. J Neurosurg. 89:911–920. 1998.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Andrews NC, Erdjument-Bromage H, Davidson
MB, Tempst P and Orkin SH: Erythroid transcription factor NF-E2 is
a haematopoietic-specific basic-leucine zipper protein. Nature.
362:722–728. 1993. View
Article : Google Scholar : PubMed/NCBI
|
10
|
Motohashi H, Katsuoka F, Engel JD and
Yamamoto M: Small Maf proteins serve as transcriptional cofactors
for keratinocyte differentiation in the Keap1-Nrf2 regulatory
pathway. Proc Natl Acad Sci USA. 101:6379–6384. 2004. View Article : Google Scholar : PubMed/NCBI
|
11
|
Jain AK, Bloom DA and Jaiswal AK: Nuclear
import and export signals in control of Nrf2. J Biol Chem.
280:29158–29168. 2005. View Article : Google Scholar : PubMed/NCBI
|
12
|
Itoh K, Chiba T, Takahashi S, Ishii T,
Igarashi K, Katoh Y, Oyake T, Hayashi N, Satoh K, Hatayama I, et
al: An Nrf2/small Maf heterodimer mediates the induction of phase
II detoxifying enzyme genes through antioxidant response elements.
Biochem Biophys Res Commun. 236:313–322. 1997. View Article : Google Scholar : PubMed/NCBI
|
13
|
Jazwa A and Cuadrado A: Targeting heme
oxygenase-1 for neuroprotection and neuroinflammation in
neurodegenerative diseases. Curr Drug Targets. 11:1517–1531. 2010.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Niture SK, Kaspar JW, Shen J and Jaiswal
AK: Nrf2 signaling and cell survival. Toxicol Appl Pharmacol.
244:37–42. 2010. View Article : Google Scholar : PubMed/NCBI
|
15
|
Tanito M, Agbaga MP and Anderson RE:
Upregulation of thioredoxin system via Nrf2-antioxidant responsive
element pathway in adaptive-retinal neuroprotection in vivo and in
vitro. Free Radic Biol Med. 42:1838–1850. 2007. View Article : Google Scholar : PubMed/NCBI
|
16
|
Du H, Ma L, Chen G and Li S: The effects
of oxyresveratrol abrogates inflammation and oxidative stress in
rat model of spinal cord injury. Mol Med Rep. 17:4067–4073.
2018.PubMed/NCBI
|
17
|
Kaelan C, Jacobsen P, Morling P and
Kakulas BA: A quantitative study of motoneurons and cortico-spinal
fibers related to function in human spinal cord injury (SCI).
Paraplegia. 27:1531989.
|
18
|
Kakulas BA: The applied neuropathology of
human spinal cord injury. Spinal Cord. 37:79–88. 1999. View Article : Google Scholar : PubMed/NCBI
|
19
|
Blight AR: Cellular morphology of chronic
spinal cord injury in the cat: Analysis of myelinated axons by
line-sampling. Neuroscience. 10:521–543. 1983. View Article : Google Scholar : PubMed/NCBI
|
20
|
Eidelberg E, Straehley D, Erspamer R and
Watkins CJ: Relationship between residual hindlimb-assisted
locomotion and surviving axons after incomplete spinal cord
injuries. Exp Neurol. 56:312–322. 1977. View Article : Google Scholar : PubMed/NCBI
|
21
|
Fehlings MG and Tator CH: The
relationships among the severity of spinal cord injury, residual
neurological function, axon counts, and counts of retrogradely
labeled neurons after experimental spinal cord injury. Exp Neurol.
132:220–228. 1995. View Article : Google Scholar : PubMed/NCBI
|
22
|
Delamarter RB and Coyle J: Acute
management of spinal cord injury. J Am Acad Orthop Surg. 7:166–175.
1999. View Article : Google Scholar : PubMed/NCBI
|
23
|
Shih AY, Johnson DA, Wong G, Kraft AD,
Jiang L, Erb H, Johnson JA and Murphy TH: Coordinate regulation of
glutathione biosynthesis and release by Nrf2-expressing glia
potently protects neurons from oxidative stress. J Neurosci.
23:3394–3406. 2003. View Article : Google Scholar : PubMed/NCBI
|
24
|
Xu W, Chi L, Xu R, Ke Y, Luo C, Cai J, Qiu
M, Gozal D and Liu R: Increased production of reactive oxygen
species contributes to motor neuron death in a compression mouse
model of spinal cord injury. Spinal Cord. 43:204–213. 2005.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Adibhatla RM and Hatcher JF: Lipid
oxidation and peroxidation in CNS health and disease: From
molecular mechanisms to therapeutic opportunities. Antioxid Redox
Signal. 12:125–169. 2010. View Article : Google Scholar : PubMed/NCBI
|
26
|
Hong Y, Yan W, Chen S, Sun CR and Zhang
JM: The role of Nrf2 signaling in the regulation of antioxidants
and detoxifying enzymes after traumatic brain injury in rats and
mice. Acta Pharmacol Sin. 31:1421–1430. 2010. View Article : Google Scholar : PubMed/NCBI
|
27
|
Jin W, Wang H, Yan W, Zhu L, Hu Z, Ding Y
and Tang K: Role of Nrf2 in protection against traumatic brain
injury in mice. J Neurotrauma. 26:131–139. 2009. View Article : Google Scholar : PubMed/NCBI
|
28
|
Jin W, Wang H, Yan W, Xu L, Wang X, Zhao
X, Yang X, Chen G and Ji Y: Disruption of Nrf2 enhances
upregulation of nuclear factor-kappaB activity, proinflammatory
cytokines, and intercellular adhesion molecule-1 in the brain after
traumatic brain injury. Mediators Inflamm. 2008:7251742008.
View Article : Google Scholar : PubMed/NCBI
|
29
|
Mao L, Wang H, Qiao L and Wang X:
Disruption of Nrf2 enhances the upregulation of nuclear
factor-kappaB activity, tumor necrosis factor-α, and matrix
metalloproteinase-9 after spinal cord injury in mice. Mediators
Inflamm. 2010:2383212010. View Article : Google Scholar : PubMed/NCBI
|
30
|
Kay MA: State-of-the-art gene-based
therapies: The road ahead. Nat Rev Genet. 12:316–328. 2011.
View Article : Google Scholar : PubMed/NCBI
|
31
|
Tasdemiroglu E and Tibbs PA: Long-term
follow-up results of thoracolumbar fractures after posterior
instrumentation. Spine (Phila Pa 1976). 20:1704–1708. 1995.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Basso DM, Beattie MS and Bresnahan JC: A
sensitive and reliable locomotor rating scale for open field
testing in rats. J Neurotrauma. 12:1–21. 1995. View Article : Google Scholar : PubMed/NCBI
|
33
|
Tonelli C, Chio IIC and Tuveson DA:
Transcriptional regulation by Nrf2. Antioxid Redox Signal.
29:1727–1745. 2018. View Article : Google Scholar : PubMed/NCBI
|
34
|
Moi P, Chan K, Asunis I, Cao A and Kan YW:
Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic
leucine zipper transcriptional activator that binds to the tandem
NF-E2/AP1 repeat of the beta-globin locus control region. Proc Natl
Acad Sci USA. 91:9926–9930. 1994. View Article : Google Scholar : PubMed/NCBI
|
35
|
Fan Z, Wirth AK, Chen D, Wruck CJ, Rauh M,
Buchfelder M and Savaskan N: Nrf2-Keap1 pathway promotes cell
proliferation and diminishes ferroptosis. Oncogenesis. 6:e3712017.
View Article : Google Scholar : PubMed/NCBI
|
36
|
Lee JM, Calkins MJ, Chan K, Kan YW and
Johnson JA: Identification of the NF-E2-related factor-2-dependent
genes conferring protection against oxidative stress in primary
cortical astrocytes using oligonucleotide microarray analysis. J
Biol Chem. 278:12029–12038. 2003. View Article : Google Scholar : PubMed/NCBI
|
37
|
Thimmulappa RK, Mai KH, Srisuma S, Kensler
TW, Yamamoto M and Biswal S: Identification of Nrf2-regulated genes
induced by the chemopreventive agent sulforaphane by
oligonucleotide microarray. Cancer Res. 62:5196–5203.
2002.PubMed/NCBI
|
38
|
Chan K, Han XD and Kan YW: An important
function of Nrf2 in combating oxidative stress: Detoxification of
acetaminophen. Proc Natl Acad Sci USA. 98:4611–4616. 2001.
View Article : Google Scholar : PubMed/NCBI
|
39
|
Chan K and Kan YW: Nrf2 is essential for
protection against acute pulmonary injury in mice. Proc Natl Acad
Sci USA. 96:12731–12736. 1999. View Article : Google Scholar : PubMed/NCBI
|
40
|
Cho HY, Jedlicka AE, Reddy SP, Kensler TW,
Yamamoto M, Zhang LY and Kleeberger SR: Role of NRF2 in protection
against hyperoxic lung injury in mice. Am J Respir Cell Mol Biol.
26:175–182. 2002. View Article : Google Scholar : PubMed/NCBI
|
41
|
Greene LA and Tischler AS: Establishment
of a noradrenergic clonal line of rat adrenal pheochromocytoma
cells which respond to nerve growth factor. Proc Natl Acad Sci USA.
73:2424–2428. 1976. View Article : Google Scholar : PubMed/NCBI
|
42
|
Uceda G, Artalejo AR, López MG, Abad F,
Neher E and García AG: Ca(2+)-activated K+ channels modulate
muscarinic secretion in cat chromaffin cells. J Physiol.
454:213–230. 1992. View Article : Google Scholar : PubMed/NCBI
|
43
|
Zhou Z and Neher E: Calcium permeability
of nicotinic acetylcholine receptor channels in bovine adrenal
chromaffin cells. Pflugers Arch. 425:511–517. 1993. View Article : Google Scholar : PubMed/NCBI
|
44
|
Nooney JM, Peters JA and Lambert JJ: A
patch clamp study of the nicotinic acetylcholine receptor of bovine
adrenomedullary chromaffin cells in culture. J Physiol.
455:503–527. 1992. View Article : Google Scholar : PubMed/NCBI
|
45
|
Horrigan FT and Bookman RJ: Releasable
pools and the kinetics of exocytosis in adrenal chromaffin cells.
Neuron. 13:1119–1129. 1994. View Article : Google Scholar : PubMed/NCBI
|
46
|
Westerink RH and Ewing AG: The PC12 cell
as model for neurosecretion. Acta Physiol (Oxf). 192:273–285. 2008.
View Article : Google Scholar : PubMed/NCBI
|
47
|
Hu R, Cao Q, Sun Z, Chen J, Zheng Q and
Xiao F: A novel method of neural differentiation of PC12 cells by
using Opti-MEM as a basic induction medium. Int J Mol Med.
41:195–201. 2018.PubMed/NCBI
|
48
|
Taylor SC, Green KN, Smith IF and Peers C:
Prion protein fragment 106–126 potentiates catecholamine secretion
from PC-12 cells. Am J Physiol Cell Physiol. 281:C1850–C1857. 2001.
View Article : Google Scholar : PubMed/NCBI
|
49
|
Shao J, Cao J, Wang J, Ren X, Su S, Li M,
Li Z, Zhao Q and Zang W: MicroRNA-30b regulates expression of the
sodium channel Nav1.7 in nerve injury-induced neuropathic pain in
the rat. Mol Pain. 12:2016. View Article : Google Scholar : PubMed/NCBI
|
50
|
Zheng W, Chong CM, Wang H, Zhou X, Zhang
L, Wang R, Meng Q, Lazarovici P and Fang J: Artemisinin conferred
ERK mediated neuroprotection to PC12 cells and cortical neurons
exposed to sodium nitroprusside-induced oxidative insult. Free
Radic Biol Med. 97:158–167. 2016. View Article : Google Scholar : PubMed/NCBI
|
51
|
Liu L, Sun T, Xin F, Cui W, Guo J and Hu
J: Nerve growth factor protects against alcohol-induced
neurotoxicity in PC12 cells via I3K/Akt/mTOR pathway. Alcohol
Alcohol. 52:12–18. 2017. View Article : Google Scholar : PubMed/NCBI
|
52
|
Gilgun-Sherki Y, Melamed E and Offen D:
Oxidative stress induced-neurodegenerative diseases: The need for
antioxidants that penetrate the blood brain barrier.
Neuropharmacology. 40:959–975. 2001. View Article : Google Scholar : PubMed/NCBI
|
53
|
van Muiswinkel FL and Kuiperij HB: The
Nrf2-ARE signalling pathway: Promising drug target to combat
oxidative stress in neurodegenerative disorders. Curr Drug Targets
CNS Neurol Disord. 4:267–281. 2005. View Article : Google Scholar : PubMed/NCBI
|
54
|
Yan W, Wang HD, Hu ZG, Wang QF and Yin HX:
Activation of Nrf2-ARE pathway in brain after traumatic brain
injury. Neurosci Lett. 431:150–154. 2008. View Article : Google Scholar : PubMed/NCBI
|
55
|
Reisman SA, Buckley DB, Tanaka Y and
Klaassen CD: CDDO-Im protects from acetaminophen hepatotoxicity
through induction of Nrf2-dependent genes. Toxicol Appl Pharmacol.
236:109–114. 2009. View Article : Google Scholar : PubMed/NCBI
|
56
|
Zhang Y, Guan L, Wang X, Wen T, Xing J and
Zhao J: Protection of chlorophyllin against oxidative damage by
inducing HO-1 and NQO1 expression mediated by PI3K/Akt and Nrf2.
Free Radic Res. 42:362–371. 2008. View Article : Google Scholar : PubMed/NCBI
|
57
|
Jansen T and Daiber A: Direct antioxidant
properties of bilirubin and biliverdin. Is there a role for
biliverdin reductase? Front Pharmacol. 3:302012.
|
58
|
Gaikwad A, Long DJ II, Stringer JL and
Jaiswal AK: In vivo role of NAD(P)H: Quinone oxidoreductase 1
(NQO1) in the regulation of intracellular redox state and
accumulation of abdominal adipose tissue. J Biol Chem.
276:22559–22564. 2001. View Article : Google Scholar : PubMed/NCBI
|
59
|
Chen X, Guo C and Kong J: Oxidative stress
in neurodegenerative diseases. Neural Regen Res. 7:376–385.
2012.PubMed/NCBI
|
60
|
Santos-Nogueira E, López-Serrano C,
Hernández J, Lago N, Astudillo AM, Balsinde J, Estivill-Torrús G,
de Fonseca FR, Chun J and López-Vales R: Activation of
lysophosphatidic acid receptor type 1 contributes to
pathophysiology of spinal cord injury. J Neurosci. 35:10224–10235.
2015. View Article : Google Scholar : PubMed/NCBI
|
61
|
Liu XY, Li CY, Bu H, Li Z, Li B, Sun MM,
Guo YS, Zhang L, Ren WB, Fan ZL, et al: The neuroprotective
potential of phase II enzyme inducer on motor neuron survival in
traumatic spinal cord injury in vitro. Cell Mol Neurobiol.
28:769–779. 2008. View Article : Google Scholar : PubMed/NCBI
|
62
|
Sun MM, Bu H, Li B, Yu JX, Guo YS and Li
CY: Neuroprotective potential of phase II enzyme inducer diallyl
trisulfide. Neurol Res. 31:23–27. 2009. View Article : Google Scholar : PubMed/NCBI
|
63
|
Vargas MR, Pehar M, Cassina P,
Martínez-Palma L, Thompson JA, Beckman JS and Barbeito L:
Fibroblast growth factor-1 induces heme oxygenase-1 via nuclear
factor erythroid 2-related factor 2 (Nrf2) in spinal cord
astrocytes: Consequences for motor neuron survival. J Biol Chem.
280:25571–25579. 2005. View Article : Google Scholar : PubMed/NCBI
|
64
|
Kanno H, Ozawa H, Dohi Y, Sekiguchi A,
Igarashi K and Itoi E: Genetic ablation of transcription repressor
Bach1 reduces neural tissue damage and improves locomotor function
after spinal cord injury in mice. J Neurotrauma. 26:31–39. 2009.
View Article : Google Scholar : PubMed/NCBI
|